Abstract:L-citrulline is a high-value amino acid with promising application in medicinal and food industries. Construction of highly efficient microbial cell factories for L-citrulline production is still an open issue due to complex metabolic flux distribution and L-arginine auxotrophy. In this study, we constructed a nonauxotrophic cell factory in Escherichia coli for high-titer L-citrulline production by coupling modular engineering strategies with dynamic pathway regulation. First, the biosynthetic pathway of L-citrulline was enhanced after blockage of the degradation pathway and introduction of heterologous biosynthetic genes from Corynebacterium glutamicum. Specifically, a superior recycling biosynthetic pathway was designed to replace the native linear pathway by deleting native acetylornithine deacetylase. Next, the carbamoyl phosphate and L-glutamate biosynthetic modules, the NADPH generation module, and the efflux module were modified to increase L-citrulline titer further. Finally, a toggle switch that responded to cell density was designed to dynamically control the expression of the argG gene and reconstruct a nonauxotrophic pathway. Without extra supplement of L-arginine during fermentation, the final CIT24 strain produced 82.1 g/L L-citrulline in a 5-L bioreactor with a yield of 0.34 g/g glucose and a productivity of 1.71 g/(L center dot h), which were the highest values reported by microbial fermentation. Our study not only demonstrated the successful design of cell factory for high-level L-citrulline production but also provided references of coupling the rational module engineering strategies and dynamic regulation strategies to produce high-value intermediate metabolites.

Metabolic Reprogramming and Biosensor-Assisted Mutagenesis Screening for High-Level Production of L-arginine in Escherichia Coli.

Metabolic engineering of Escherichia coli for efficient production of l-arginine

Reconstructing a Recycling and Nonauxotroph Biosynthetic Pathway in Escherichia Coli Toward Highly Efficient Production of L-citrulline.

A novel strategy for l-arginine production in engineered Escherichia coli

L-Arginine Production in Corynebacterium Glutamicum: Manipulation and Optimization of the Metabolic Process

Systems engineering of Escherichia coli for high-level l-alanine production

Production of l-phenylalanine from glucose by metabolic engineering of wild type Escherichia coli W3110

Phenotype-genotype Mapping Reveals the Betaine-Triggered L-arginine Overproduction Mechanism in Escherichia Coli.

Improvement of the ammonia assimilation for enhancing L-arginine production of Corynebacterium crenatum

Design of a Genetically Encoded Biosensor for High-Throughput Screening and Engineering 5-Aminolevulinic Acid Hyper-Producing Escherichia coli

[Metabolic engineering of the substrate utilization pathway in Escherichia coli increases L-lysine production]

Enhanced production of L-arginine by improving carbamoyl phosphate supply in metabolically engineered Corynebacterium crenatum

Genetic Engineering of Escherichia Coli to Improve L-phenylalanine Production

Rerouting Fluxes of the Central Carbon Metabolism and Relieving Mechanism-Based Inactivation of l -Aspartate-α-decarboxylase for Fermentative Production of β-Alanine in Escherichia coli

Metabolic Engineering of Escherichia Coli W3110 for the Production of L-Methionine

Metabolic engineering of E. coli for β-alanine production using a multi-biosensor enabled approach

Metabolic engineering of Escherichia coli for the production of 5-aminolevulinic acid based on combined metabolic pathway modification and reporter-guided mutant selection (RGMS)

L-Cysteine Production In Escherichia Coli Based On Rational Metabolic Engineering And Modular Strategy

Multiplex modification of Escherichia coli for enhanced β-alanine biosynthesis through metabolic engineering

Combinatorial Metabolic Engineering of <i>Escherichia coli</i> for Enhanced L-Cysteine Production: Insights into Crucial Regulatory Modes and Optimization of Carbon-Sulfur Metabolism and Cofactor Availability

Utilizing a high-throughput visualization screening technology to develop a genetically encoded biosensor for monitoring 5-aminolevulinic acid production in engineered Escherichia coli